Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies
A new treatment strategy is needed, as the efficacy of triple therapy containing clarithromycin—the current standard treatment for Helicobacter pylori infection—is declining. Increasing antibiotic resistance of H. pylori is the most significant factor contributing to eradication failure. Thus, selec...
Saved in:
Main Authors: | Ju Yup Lee, Kyung Sik Park |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Gastroenterology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2016/9086581 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Optimal First-Line Therapy of Helicobacter pylori Infection in Year 2012
by: Chao-Hung Kuo, et al.
Published: (2012-01-01) -
Efficacy and Safety of the Triple Therapy Containing Ilaprazole, Levofloxacin, and Amoxicillin as First-Line Treatment in Helicobacter pylori Infections
by: Hyo Jun Ahn, et al.
Published: (2017-01-01) -
High Dose Ilaprazole/Amoxicillin as First-Line Regimen for Helicobacter pylori Infection in Korea
by: WonGun Kwack, et al.
Published: (2016-01-01) -
Application of Minocycline-Containing Bismuth Quadruple Therapies as First-Line Regimens in the Treatment of Helicobacter pylori
by: Lingyun Zhang, et al.
Published: (2019-01-01) -
Helicobacter pylori: Infection and New Perspective for the Treatment
by: Teresa Fasciana, et al.
Published: (2019-01-01)